AMRX
Amneal Pharmaceuticals
$16.87
−$0.38 (−2.2%)Sep 10, 2026
Key metrics
The numbers that frame AMRX today
- Market cap
- $5.39B
- P/E (TTM)
- 34.2
- EV / FCF
- 96.0
- Gross margin
- 39.3%
- EV / Sales
- 2.6
- ROIC
- 9%
- Div yield
- 0%
- Debt / equity
- 84.5
- 52wk Low
- $9.49
- 52wk High
- $19.26
Growth
Revenue and earnings trend for AMRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AMRX
Is Amneal Pharmaceuticals a good buy?
Yes. Amneal Pharmaceuticals has strong quality and excellent momentum. Both signals support the setup. Growth looks poor, a caveat that does not overturn the setup. We think Amneal Pharmaceuticals is selling at a fair price.
What is the market capitalization of AMRX?
Amneal Pharmaceuticals's market capitalization is $5.39B.
What is the P/E ratio for AMRX stock?
Amneal Pharmaceuticals's current P/E ratio is 34.2.
What is the 52-week high for AMRX stock?
The 52-week high for Amneal Pharmaceuticals is $19.26. The current close of $16.87 is 12.4% below that high.
What is the 52-week low for AMRX stock?
The 52-week low for Amneal Pharmaceuticals is $9.49. The current close of $16.87 is 77.8% above that low.
Does AMRX stock pay dividends?
Amneal Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AMRX?
Amneal Pharmaceuticals's Debt / Equity ratio is 84.54.